Record ID: MS-N095
Family: Bee-derived products and supportive care
Clinical question: Does topical or oral propolis prevent or reduce oral mucositis during cancer treatment?
Evidence label: Small randomized trials; possible benefit, low certainty
Evidence at a glance
Benefit: Several small trials report less or later mucositis.
Certainty: Low because trials are small, formulations and comparators differ, and recent reviews identify risk-of-bias concerns.
Risk: Allergic reactions are the main practical concern, especially with bee-product or balsam allergy; product composition varies.
Cancer control: This concerns symptom prevention and healing, not tumor response or survival.
What was studied
A 2017 pilot randomized 60 people receiving adjuvant doxorubicin/cyclophosphamide for breast cancer to a dry propolis extract standardized to 8%–12% galangin plus sodium-bicarbonate mouth rinses, or bicarbonate rinses alone. Oral mucositis was assessed through day 21.
Other head-and-neck radiotherapy studies used propolis mouthwash or gel. A 2026 review found four clinical trials totaling 134 participants, with substantial variation in formulations and outcome scales.
What the results mean
In the breast-cancer pilot, no participant in the propolis arm developed mucositis above grade 1, compared with 16.7% in the control arm (P=.02). Two propolis recipients (6.7%) had suspected skin reactions.
The 2026 review concluded that propolis may reduce severity, particularly with mouthwash, but emphasized the need for larger trials and standardized products. These studies do not establish one transferable dose or formulation.
Limits and uncertainty
Some trials were pilots, blinding was difficult or incompletely described, and supportive oral-care comparators differed. Reviews cannot turn heterogeneous small studies into proof.
“Propolis” is a chemically variable resin influenced by botanical source, extraction and contaminants. Results cannot be generalized to every commercial product.
Safety and practical context
Avoid propolis when there is a known allergy to bee products, balsam of Peru or related resins. Stop for rash, swelling, wheeze or worsening mouth irritation and seek urgent help for breathing difficulty.
Mucositis can impair hydration, nutrition and infection control. Fever, inability to swallow fluids or uncontrolled pain needs prompt oncology assessment.
Questions for the care team
- Which standardized formulation was studied?
- Could allergy history make propolis unsafe?
- What oral-care protocol and evidence-based mucositis prevention should continue?
- How will grade, pain, intake and infection risk be monitored?
Sources
- Breast-cancer chemotherapy pilot RCT (PMID 28840622)
- 2026 review of propolis for radiotherapy-related mucositis (PMID 42138875)
Funding and conflicts
Funding and conflicts were not fully verified across the small trials. No commercial product should claim equivalence without matching formulation and independent testing.
Last literature search: October 21, 2026
Record appraised: October 21, 2026
This educational record is not individualized medical advice. Research doses and schedules are not personal prescriptions; do not delay or replace evidence-based cancer care.
